Weighted Average Number of Shares Outstanding, Diluted of Compass Therapeutics, Inc. from 30 Sep 2024 to 31 Dec 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Compass Therapeutics, Inc. annual and quarterly Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Sep 2024 to 31 Dec 2024.
  • Compass Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2024 was 137,600,000.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)

Compass Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 137,400,000 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY

Compass Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 137,600,000 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.